ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 3531 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 3531; 2) Community: the network communities that were significantly associated with the response to NSC 3531; 3) Molecule: the relationships between components within communities and NSC 3531; 4) MDR: the compounds that were significantly associated with the NSC 3531.

NSC Compound Enrichment Correlation
NSC 676772 Olean-12-en-28-oic acid, 3-.beta.-[2-O-(.beta.-D-glucopyranosyl)- .beta.-D-glucopyranosyloxy]-, [2-O-[4-O-(.beta.-D-xylopyranosyl)-6-deoxy- .beta.-D-gulopyranosyl]-.beta.-L-arbinopyranosyl] ester 0.0474314077111082 -0.24359102
NSC 601852 Veracoquinazole 0.0480633950058471 0.22965906
NSC 603086 2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (Z)- 0.0480633950058471 0.27470507
NSC 603555 2-Propen-1-one, 2-[(dimethylamino)methyl]-1-(4-phenoxy phenyl)-, hydrochloride 0.0480633950058471 0.28016261
NSC 617823 4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride 0.0480633950058471 0.26622829
NSC 619102 4-Methoxy-1,5-benzothiazepine-1,1-dioxide 0.0480633950058471 0.14353105
NSC 623436 TGF.alpha.-PE40 0.0480633950058471 -0.22274692
NSC 623639 Cyclopentane-1,3-dimethanamine, N,N,N,N',N',N'-hexamethyl-2-oxo-, iodide 0.0480633950058471 0.21579113
NSC 624153 Null 0.0480633950058471 0.14977944
NSC 635922 Null 0.0480633950058471 0.39687436
Total:79  Current:75    [First] [Prev] [Next] [Last]